These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sugar substitutes. Americans opt for sweetness and lite. Henkel J FDA Consum; 1999; 33(6):12-6. PubMed ID: 10628311 [No Abstract] [Full Text] [Related]
6. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals. Greene JA; Watkins ES N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749 [No Abstract] [Full Text] [Related]
7. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study. Schwartz JL N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733 [No Abstract] [Full Text] [Related]
8. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act. Cooper DE Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915 [No Abstract] [Full Text] [Related]
9. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
10. Aspartame bioassay findings portend human cancer hazards. Huff J; LaDou J Int J Occup Environ Health; 2007; 13(4):446-8. PubMed ID: 18085058 [TBL] [Abstract][Full Text] [Related]
11. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]
12. Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame. Abdo KM; Camargo CA; Davis D; Egilman D; Epstein SS; Froines J; Hattis D; Hooper K; Huff J; Infante PF; Jacobson MF; Teitelbaum DT; Tickner JA Int J Occup Environ Health; 2007; 13(4):449-50. PubMed ID: 18085059 [No Abstract] [Full Text] [Related]
13. The 1941 sulfathiazole disaster and the birth of good manufacturing practices. Swann JP Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769 [No Abstract] [Full Text] [Related]
14. Learning about the safety of drugs--a half-century of evolution. Avorn J N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034 [No Abstract] [Full Text] [Related]
15. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly. Vladeck DC Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967 [No Abstract] [Full Text] [Related]
16. Rights, patents, markets and the global AIDS pandemic. Gathii JT Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139 [No Abstract] [Full Text] [Related]
17. How sweet is it? Briggs TA Dent Abstr; 1985 Feb; 30(2):76-8. PubMed ID: 3855765 [No Abstract] [Full Text] [Related]
19. Losing deference in the FDA's second century: judicial review, politics, and a diminished legacy of expertise. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):939-80. PubMed ID: 18618965 [No Abstract] [Full Text] [Related]
20. Shattuck lecture. Innovation, regulation, and the FDA. Hamburg MA N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835 [No Abstract] [Full Text] [Related] [Next] [New Search]